Skip to content

DR MIGLIONICO

Active
Private limited companyfounded 2024active for 2 yearsPangaertstraat 32, 1083 Ganshoren, BelgiumKBO/BCE: BE 1008.690.528
Summary

DR MIGLIONICO has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €210,515 and a net result of €210,515. Its solvency ranks better than 37% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
DR MIGLIONICOActiveChecked score 95/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€449,379total assets 2025
Staff
1 FTE
Equity
€210,515
Profit
€210,515
Turnover not published (micro format)
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 12 days early
Why 95lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.17, cash €220,305Size: total assets €449,379Equity €210,515 (46.8% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 57% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength
Strong
Solvency 72
equity 46.8% of total assets
Liquidity 73
short-term debt 53.2% · cash 49.0%
Profitability 100
return on assets 46.8%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 05-2025: 0.3% 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025 08-2025: 0.3%● unchanged vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.4%▲ +0.1 percentage points vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025highest value 02-2026: < 0.1%▼ -0.4 percentage points vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €19,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity tight (current ratio 1.17, below the usual 1.5; short-term debt: 53.2% and cash: 49% of total assets), and 53.2% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 38% on solvency, 54% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.17, cash €220,305
NBB · annual accounts
lowers risk · Size: total assets €449,379
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €210,515 (46.8% of total assets)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 19-01-2026, 12 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
12 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. IncorporationAppointment: Luca MIGLIONICO (director) ·…

Key points

  • Positive: Among the best 11% on net resultsector median €60,202 · 20,591 companies €210,515 View
  • One director decidessole director in office 1 View
  • Total assets 2025first financial year filed €449,379 View

By topic

Financials

Financial year
2025
Total assets
€449,379
Profit
€210,515
Solvency
46.8%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
23-04-2024
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
31
Annual meeting
Last Thursday of December at 18:00
Statutory auditor
No statutory auditor
Go to Articles of association

Key facts about DR MIGLIONICO

What is the company number of DR MIGLIONICO?
1008.690.528. In Belgium the VAT number is the company number with BE in front: BE 1008.690.528.
Where is DR MIGLIONICO based?
The registered office is at Pangaertstraat 32, 1083 Ganshoren.Company details
What does DR MIGLIONICO do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR MIGLIONICO?
Private limited company (BV).
When was DR MIGLIONICO founded?
On 23-04-2024.
Is DR MIGLIONICO still active?
Yes, DR MIGLIONICO is an active enterprise in the KBO register.
How many employees does DR MIGLIONICO have?
On average 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of DR MIGLIONICO?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is DR MIGLIONICO profitable?
In financial year 2025, DR MIGLIONICO made a profit of €210,515.
Where can I find the annual accounts of DR MIGLIONICO?
DR MIGLIONICO filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Companies related to DR MIGLIONICO

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Is the workforce growing, and do people stay?Employer check

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure